Clinical trial · no report yet · Phase 3
CARMENA
Clinical Trial to Assess the Importance of Nephrectomy
- NCT00930033 ↗
- Completed
- Assistance Publique - Hôpitaux de Paris
- 44 commentary sources found
- Deep
We haven't built a report for this trial yet. This page shows the registry record and the public commentary we found that names the trial. A report reads that commentary and sets out what clinicians said about the trial, each point linked to its source. How reports are made.
Commentary we found
Podcasts, YouTube videos and X posts in our index that name this trial. A report screens them, searches for more and cites what clinicians said when it is built.
| Channel | Found | |
|---|---|---|
| X threads | 33 | |
| Podcasts | 6 | |
| YouTube | 5 |
The trial
ClinicalTrials.gov- Official title
- Randomized Phase III Trial Evaluating the Importance of Nephrectomy in Patients Presenting With Metastatic Renal Cell Carcinoma Treated With Sunitinib
- Phase
- Phase 3
- Status
- Completed
- Conditions
- Metastatic Renal Cell Carcinoma
- Interventions
- Nephrectomy; Sunitinib alone
- Arms
- A · Active comparator
- B · Experimental
- Enrollment
- 452
- Primary outcomes
- The primary endpoint is overall survival.
- Sponsor
- Assistance Publique - Hôpitaux de Paris with Pfizer, URC-CIC Paris Descartes Necker Cochin
- Start
- Sep 9, 2009
- Primary completion
- Oct 22, 2018
- Results posted
- No
- Registry record
- NCT00930033 · updated Sep 5, 2025
Publications
linked from the registry- Mejean A, Ravaud A, Thezenas S, Chevreau C, Bensalah K, Geoffrois L, Thiery-Vuillemin A, Cormier L, Lang H, Guy L, Gravis G, Rolland F, Linassier C, Lechevallier E, Oudard S, Laguerre B, Gross-Goupil M, Bernhard JC, Colas S, Albiges L, Lebret T, Treluyer JM, Timsit MO, Escudier B. Sunitinib Alone or After Nephrectomy for Patients with Metastatic Renal Cell Carcinoma: Is There Still a Role for Cytoreductive Nephrectomy? Eur Urol. 2021 Oct;80(4):417-424. doi: 10.1016/j.eururo.2021.06.009. Epub 2021 Jun 27. PubMed 34187771
- Mejean A, Ravaud A, Thezenas S, Colas S, Beauval JB, Bensalah K, Geoffrois L, Thiery-Vuillemin A, Cormier L, Lang H, Guy L, Gravis G, Rolland F, Linassier C, Lechevallier E, Beisland C, Aitchison M, Oudard S, Patard JJ, Theodore C, Chevreau C, Laguerre B, Hubert J, Gross-Goupil M, Bernhard JC, Albiges L, Timsit MO, Lebret T, Escudier B. Sunitinib Alone or after Nephrectomy in Metastatic Renal-Cell Carcinoma. N Engl J Med. 2018 Aug 2;379(5):417-427. doi: 10.1056/NEJMoa1803675. Epub 2018 Jun 3. PubMed 29860937
- Leon L, Garcia-Figueiras R, Suarez C, Arjonilla A, Puente J, Vargas B, Mendez Vidal MJ, Sebastia C. Recommendations for the clinical and radiological evaluation of response to treatment in metastatic renal cell cancer. Target Oncol. 2014 Mar;9(1):9-24. doi: 10.1007/s11523-013-0304-7. Epub 2013 Dec 12. PubMed 24338498